Stem cells transplanted for treatment of Parkinson’s disease

Japanese researchers have last week transplanted stem cells into a patient’s brain as part of an experimental therapy for Parkinson’s disease. The team at Kyoto University used induced Pluripotent Stem (iPS) cells for their procedure. These iPS cells have the capacity to turn into any cell in the body.

Stem cells - 3d illustration. Image Credit: Giovanni Cancemi / Shutterstock
Stem cells - 3d illustration. Image Credit: Giovanni Cancemi / Shutterstock

For the study they found a male patient of Parkinson’s disease in his fifties who agreed for this experiment. After the operation where the cells were injected last month, the man was stable. He will now be followed up for two years before conclusive information regarding the safety and efficacy of the procedure can be ascertained say the researchers. At the first round the team injected 2.4 million iPS cells onto his left side of the brain in a three hour long operation.

Over the next six months, he would be monitored closely and if no harm is noted another 2.4 million iPS cells would be implanted onto the right side of the brain. These iPS cells come from healthy donors and are expected to develop into dopamine-producing brain cells that have been damaged in the patient’s own brain.

A total of seven patients between ages 50 and 69 have been included for this study. Kyoto University professor Jun Takahashi thanked the participants for volunteering to participante in this study. This human study follows earlier successful trials on monkeys explain the researchers.

“By also cooperating with companies, we want to develop a mass production system that enables us to deliver nerve cells derived from iPS cells to all over the world,” said Jun Takahashi, a professor at the university’s Center for iPS Cell Research and Application who led the research team, at a news conference. He elaborated on the process of the three-hour operation he performed, "we made a hole in the frontal part of the left side of the head and transplanted some 2.4 million cells, adding that the patient smiled with relief after the operation."

If successful this could revolutionize Parkinson’s disease treatment say experts. This disease of the brain and nerves affects around 10 million people worldwide and at present it is incurable with treatment available to just curb the symptoms for a period of time.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, November 11). Stem cells transplanted for treatment of Parkinson’s disease. News-Medical. Retrieved on December 11, 2024 from https://www.news-medical.net/news/20181111/Stem-cells-transplanted-for-treatment-of-Parkinsons-disease.aspx.

  • MLA

    Mandal, Ananya. "Stem cells transplanted for treatment of Parkinson’s disease". News-Medical. 11 December 2024. <https://www.news-medical.net/news/20181111/Stem-cells-transplanted-for-treatment-of-Parkinsons-disease.aspx>.

  • Chicago

    Mandal, Ananya. "Stem cells transplanted for treatment of Parkinson’s disease". News-Medical. https://www.news-medical.net/news/20181111/Stem-cells-transplanted-for-treatment-of-Parkinsons-disease.aspx. (accessed December 11, 2024).

  • Harvard

    Mandal, Ananya. 2018. Stem cells transplanted for treatment of Parkinson’s disease. News-Medical, viewed 11 December 2024, https://www.news-medical.net/news/20181111/Stem-cells-transplanted-for-treatment-of-Parkinsons-disease.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aging of lung stem cells drives iron deficiency and reduces capacity for tumor formation